Cypress Capital Management (Wyoming)’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-7,342
Closed -$340K 264
2021
Q2
$340K Hold
7,342
0.26% 64
2021
Q1
$322K Hold
7,342
0.28% 63
2020
Q4
$301K Hold
7,342
0.26% 61
2020
Q3
$289K Sell
7,342
-2,265
-24% -$83.5K 0.26% 56
2020
Q2
$331K Sell
9,607
-1,700
-15% -$52.8K 0.33% 55
2020
Q1
$316K Sell
11,307
-2,818
-20% -$93.8K 0.44% 39
2019
Q4
$491K Buy
+14,125
New +$478K 0.46% 47

Other funds holding FFTY

Cypress Capital Management (Wyoming)'s FFTY Position: Q3 2021 in Review

Cypress Capital Management (Wyoming) sold out of CapForce IBD 50 ETF (FFTY) in Q3 2021, closing a stake of 7,342 shares — an estimated $340K sold.

Cypress Capital Management (Wyoming) first reported a position in FFTY in Q4 2019 and held it in 7 quarters. The position peaked at $491K in Q4 2019. 70 funds tracked by Wall St. Rank hold FFTY as of Q3 2021.

  • Cypress Capital Management (Wyoming) reported no remaining CapForce IBD 50 ETF position as of Q3 2021 after selling out during the quarter.
  • Cypress Capital Management (Wyoming) sold 7,342 CapForce IBD 50 ETF shares in Q3 2021, an estimated $340K.
  • Cypress Capital Management (Wyoming) first reported a position in CapForce IBD 50 ETF in Q4 2019 and held it in 7 quarters.
  • Cypress Capital Management (Wyoming)'s CapForce IBD 50 ETF position peaked at $491K in Q4 2019.
  • 70 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q3 2021.

Based on Cypress Capital Management (Wyoming)'s 13F filing for Q3 2021, filed 4 Nov 2021.